Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
31,373,251
-
Share change
-
+16,087,549
-
Total reported value
-
$378,193,285
-
Price per share
-
$12.05
-
Number of holders
-
54
-
Value change
-
+$193,924,831
-
Number of buys
-
44
-
Number of sells
-
5
Institutional Holders of AMRYT PHARMA PLC - SPONSORED ADS (AMYT) as of Q3 2021
As of 30 Sep 2021,
AMRYT PHARMA PLC - SPONSORED ADS (AMYT) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,373,251 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Athyrium Capital Management, LP, Rubric Capital Management LP, MPM ASSET MANAGEMENT LLC, EdgePoint Investment Group Inc., UBS OCONNOR LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Aquilo Capital Management, LLC, Rock Springs Capital Management LP, and Man Group plc.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.